What’s New in Ontosight® Terminal 1.1 A Complete Guide toRead More
What’s New in Ontosight® Terminal 1.1
Life Science
Accelerate your research and discovery in life sciences
What is OntosightⓇ Discover? OntosightⓇ is an end to end search and discovery platform for life sciences. It leverages artificial intelligence and life science ontology build by Innoplexus to generate continuous insights across preclinical and clinical stages of drug development, spanning all major therapeutic areas and indications. OntosightⓇ Discover is a module of the platform that enables real-time …
Accelerate your research and discovery in life sciences Read More »
An AI-based solution to extract real-time insights from the ever-growing scientific data
The pharmaceutical industry saves millions of lives every year, and in doing so, it needs to constantly improve existing therapies, find new ones, and take advantage of the large volume of growing scientific and medical data. It is often a herculean task to access all relevant data in real time, let alone make connections in …
An AI-based solution to extract real-time insights from the ever-growing scientific data Read More »
Virtual pharma – now for real?
Imagining an integrated virtual pharma company The evolution of the pharma business model Over the last decades, the advances in medical science, the growing competition and the demands of the payers have led to permanent changes and adaptations of the pharma business model. Even the biggest companies do not do everything in-house. Instead, the industry …
Innoplexus Assists in Biomarker Identification
In 2019, Innoplexus worked with Novartis on a pilot program that used Innoplexus’s proprietary artificial intelligence solutions and publicly available data to seek to identify baseline biomarkers of response. Innoplexus was talking to Eric Hughes – global development unit head for immunology, hepatology, and dermatology at Novartis: What is your role at Novartis, and what …
Impact of AI and Digitalization on R&D in Biopharmaceutical Industry
Data are not the new gold – but the ability to put them together in a relevant and analyzable way is Innoplexus has contributed to big data and Artificial Intelligence (AI) projects in pharma R&D. In this paper we share our point of view on the impact of AI enabled technologies on R&D that can …
Impact of AI and Digitalization on R&D in Biopharmaceutical Industry Read More »
Why AI Is a Practical Solution for Pharma
Artificial intelligence, or AI, is gaining more attention in the pharma space these days. At one time evoking images from futuristic science fiction, it now plays a significant role in smartphones, cars, search engines, and financial transactions. But what, exactly, is artificial intelligence? It is a set of very specialized algorithms trained to solve very …
You Can’t Find the Needle If You Don’t Know It Exists
This blog is adapted from my book titled “Inside the Cockpit: Navigating the Complexity of Drug Development with AI and Blockchain”. Full copies are available here. In December 2014, a twenty-nine-year-old investor named Vivek Ramaswamy bought a patent from GlaxoSmithKline (GSK) for $5 million. The patent covered an Alzheimer’s drug candidate that had failed GSK’s …
You Can’t Find the Needle If You Don’t Know It Exists Read More »
Build KOL Connections and Leverage Their Networks to Influence Stakeholders
Key opinion leaders (KOLs) play a central role in creating brand value for a pharmaceutical company. They are not only the face of the brand for the outside world but also an irreplaceable resource within the company, bringing new insights and overall enhancement throughout the drug development process. So, who are the KOLs? When a …
Build KOL Connections and Leverage Their Networks to Influence Stakeholders Read More »
